Plain-English translation of NCT06339593 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
Read our Cystic Fibrosis research guide βPhase 1 β Testing in a small group (usually 20β80 people) to find a safe dose and watch for side effects.
This trial is testing whether advanced MRI imaging can sensitively detect changes in your lungs when you adjust how often you do mechanical airway clearance therapy. Cystic fibrosis causes thick mucus buildup in the lungs, and airway clearance therapy helps clear itβbut it takes about 2 hours every day, which is very burdensome. With newer CF medications like Trikafta now available and working really well, some patients and families wonder if they need to do airway clearance as often.
Right now, doctors don't have a good way to quickly and sensitively measure whether your lungs are staying healthy when you change your airway clearance routine. The study aims to see if MRI can detect small lung changes that regular breathing tests might miss, so doctors and patients can make safer decisions about adjusting this demanding therapy.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You would come for multiple study visits where you'll have MRI scans of your lungs (without radiation), standard breathing tests, and possibly washout tests that measure how your lungs clear air. Depending on which group you're in, you might be asked to increase, decrease, or restart your airway clearance therapy at different frequencies for short periods while the research team monitors how your lungs respond. The study takes place over several weeks, and your treating CF doctor will be involved and agree to the study plan.
AI-generated summary from trial data Β· Jun 3, 2026 Β· Not medical advice
United States